- Arrival moves closer to production, with more demos and test trials occurring as microfactories in Rock Hill and Bicester move closer towards completion.
- 59,000 units in non-binding orders and LOIs hints that the company could be able to meet early growth targets in 2022, while doubts remain for 2024.
- An attractive valuation at 0.6x 2024 revenues relies heavily on execution risk within microfactory success, cost management and ability to scale.
- Other risks do remain, but that growth potential, even if 2024's outlook is halved to $7 billion in revenues, could make shares worth a speculative bet.
For further details see:
Arrival Might Be Worth A Speculative Look Here